PEGAPTANIB SODIUM - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for pegaptanib sodium and what is the scope of patent protection?
Pegaptanib sodium
is the generic ingredient in one branded drug marketed by Bausch And Lomb Inc and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for PEGAPTANIB SODIUM
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 1 |
Clinical Trials: | 34 |
Patent Applications: | 4,574 |
DailyMed Link: | PEGAPTANIB SODIUM at DailyMed |
Recent Clinical Trials for PEGAPTANIB SODIUM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Vision Research Foundation | Phase 2 |
Greater Houston Retina Research | Phase 3 |
Postgraduate Institute of Medical Education and Research | N/A |
US Patents and Regulatory Information for PEGAPTANIB SODIUM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bausch And Lomb Inc | MACUGEN | pegaptanib sodium | INJECTABLE;INTRAVITREAL | 021756-001 | Dec 17, 2004 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |